| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/21/2010 | EP2207764A2 Hydrocortisone derivatives and use thereof for therapeutic or cosmetic indications |
| 07/21/2010 | EP2207598A1 Methods and compositions for treating dry eye |
| 07/21/2010 | EP2207570A2 Drug carriers |
| 07/21/2010 | EP2207555A1 Novel compounds for the treatment or alleviation of edema, and methods for their use |
| 07/21/2010 | EP2207554A2 C4'-substituted-2-deoxyadenosine analogs and methods of treating hiv |
| 07/21/2010 | EP2207553A1 Potent combinations of zidovudine and drugs that select for the k65r mutation in the hiv polymerase |
| 07/21/2010 | EP2207551A1 Use of 3, 11b-cis-dihydrotetrabenazine in the treatment of multiple sclerosis and autoimmune myelitis |
| 07/21/2010 | EP2207550A2 Tetrahydroquinoline derivatives for treating post-traumatic stress disorders |
| 07/21/2010 | EP2207549A1 Modulators of muscarinic receptors |
| 07/21/2010 | EP2207548A1 Breast cancer therapy |
| 07/21/2010 | EP2207547A2 5-lipoxygenase-activating protein (flap) inhibitors |
| 07/21/2010 | EP2207545A2 Methods for treating post-operative effects such as spasticity and shivering with clonidine |
| 07/21/2010 | EP2207543A2 Omega-3 fatty acids, hydroxy polyunsaturated fatty acids, lipoxin compounds, or oxylipin compounds for treating autoimmune diseases or inhibiting immune function |
| 07/21/2010 | EP2207542A2 A method of hormone suppression in humans |
| 07/21/2010 | EP2207541A1 Use of sulfonyl-substituted 2-sulfonylaminobenzoic acid n-phenylamides in the treatment of pain |
| 07/21/2010 | EP2207540A1 Cyclopropyl aryl amide derivatives and uses thereof |
| 07/21/2010 | EP2207538A1 Compositions comprising cetirizine and a non beta-2-adrenoreceptor agonist, a beta-2-adrenoreceptor agonist or an anti -inflammatory and the use thereof for the treatment of respiratory disorders |
| 07/21/2010 | EP2207537A2 Systemic pro-hemostatic effect of sympathicomimetics with agonistic effects on -adrenergic and/or -adrenergic receptors of the sympathetic nervous system, related to improved clot strength |
| 07/21/2010 | EP2207532A2 Pharmaceutical compositions of rhein or diacerein |
| 07/21/2010 | EP2207531A1 Self-emulsifying pharmaceutical compositions of rhein or diacerein |
| 07/21/2010 | EP2207527A2 Methods for administering corticosteroid formulations |
| 07/21/2010 | EP2207526A2 Process for the manufacure of a pharmaceutical product comprising citric acid, magnesium oxide, potassium bicarbonate and sodium picosulfate, pharmaceutical composition comprising granules obtained by such process and intermediate products thereof |
| 07/21/2010 | EP2207523A1 C-19 steroids for cosmetic and further uses |
| 07/21/2010 | EP2207509A1 Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity |
| 07/21/2010 | EP2207429A2 Lipid compositions for the treatment of gastro-intestinal disorders and the promotion of intestinal development and maturation |
| 07/21/2010 | EP2207424A1 Compositions and methods for treating purpura |
| 07/21/2010 | EP2207420A1 Anti-glycation methods and compositions |
| 07/21/2010 | EP2139493B1 Compositions containing compounds having steroid structure and their use for inducing the proliferation and differentiation of stem cells of the organism |
| 07/21/2010 | EP2099787B1 Aminopyrimidines useful as inhibitors of protein kinases |
| 07/21/2010 | EP2051703B1 Pharmaceutical combination comprising nucleotide and nucleoside reverse transcriptase inhibitors (such as tenofovir and lamivudine) in different parts of the dosage unit |
| 07/21/2010 | EP2029089B1 O/w emulsion for caring for hands |
| 07/21/2010 | EP1981504B1 Thiadiazole derivatives for the treatment of neuro degenerative diseases |
| 07/21/2010 | EP1960390B1 Biaryl compounds useful as agonists of the gpr38 receptor |
| 07/21/2010 | EP1940840B1 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof |
| 07/21/2010 | EP1893573B1 Inhibitors of hcv replication |
| 07/21/2010 | EP1844044B1 Thiazole-4-carboxamide derivatives as mglur5 antagonists |
| 07/21/2010 | EP1809622B1 Inhibitors of the interaction between mdm2 and p53 |
| 07/21/2010 | EP1796730B1 Stabilized leukotriene b4 (ltb4) agent pharmaceutical |
| 07/21/2010 | EP1751128B1 Chromene-derivatives with anti-tubulin and vascular targeting activity |
| 07/21/2010 | EP1750523B1 Compositions and methods for reducing or preventing obesity |
| 07/21/2010 | EP1742623B1 2-methylthiazolidine-2,4-dicarboxylic acid-containing combination preparations |
| 07/21/2010 | EP1732604B1 Methods of treating hiv infection |
| 07/21/2010 | EP1727901B1 Materials and methods for treatment of cancer |
| 07/21/2010 | EP1725120B1 Compositions, kits, and methods utilising an added boron source |
| 07/21/2010 | EP1613621B1 Prostaglandin analogs as ep4 receptor agonists |
| 07/21/2010 | EP1610789B1 Bicyclic piperidine derivatives as melanocortin-4 receptor agonists |
| 07/21/2010 | EP1587505B1 Wound and skin care compositions |
| 07/21/2010 | EP1581204B1 Treatment of melanoma with p-aminobenzoic acid (PABA) |
| 07/21/2010 | EP1539202B1 Compositions based on plant extracts for the treatment of cancer |
| 07/21/2010 | EP1487444B9 Use of pyridyl amides as inhibitors of angiogenesis |
| 07/21/2010 | EP1474121B1 Synergistic association of (-)- gossypol with docetaxel or paclitaxel for cancer treatment |
| 07/21/2010 | EP1411900B1 PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs |
| 07/21/2010 | EP1399445B9 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists |
| 07/21/2010 | EP1345602B1 Wound healing |
| 07/21/2010 | EP1265866B1 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 07/21/2010 | EP1259243B2 Bupropion metabolites and methods of their synthesis and use |
| 07/21/2010 | EP1181034B1 Combinations of immunosuppressive agents for the treatment or prevention of graft rejections |
| 07/21/2010 | EP1143970B1 Pyridine compounds, use and preparation thereof |
| 07/21/2010 | EP1079825B1 Compounds that inhibit the binding of integrins to their receptors |
| 07/21/2010 | EP0748228B1 powder FOR THE PROVOCATION OF AIR PASSAGE NARROWING AND/OR THE INDUCTION OF SPUTUM |
| 07/21/2010 | EP0702566B1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
| 07/21/2010 | CN1981750B Soluble A-SH CoA-SH Q10 composition and its production method |
| 07/21/2010 | CN1976910B Novel 2,4-diaminothiazol-5-one derivatives |
| 07/21/2010 | CN1964954B Pyrazolo pyrimidines |
| 07/21/2010 | CN1960977B Quinazoline derivative |
| 07/21/2010 | CN1930125B Biphenyl compounds useful as muscarinic receptor antagonists |
| 07/21/2010 | CN1918126B Ionic UV-A sunscreens and compositions containing them |
| 07/21/2010 | CN1917903B New combinations of an anti emetic agent and an enkephalinase inhibitor |
| 07/21/2010 | CN1886389B Quinoxaline compounds |
| 07/21/2010 | CN1872083B Application of monarda glycoside in preparing medicine for treating or preventing hemorrhagic disease |
| 07/21/2010 | CN1845723B Methods for the treatment of endometriosis |
| 07/21/2010 | CN1833644B Abrotine, its derivative dihydro-abrotine, artemether, arteether and arte sunate in use of pharmacy |
| 07/21/2010 | CN1827137B Blood-activating bone-resetting capsule |
| 07/21/2010 | CN1826310B Novel aminobenzophenone compounds |
| 07/21/2010 | CN1823747B Paeonol film coated drip pill and its preparation method |
| 07/21/2010 | CN1751031B HIV replication inhibiting pyrimidines |
| 07/21/2010 | CN1732946B Pharmaceutical composition for preventing and treating poultry ascites |
| 07/21/2010 | CN1730034B Pharmaceutical composition for treating acute pneumonia, urinary tract infection and cholecystitis |
| 07/21/2010 | CN101784559A Binding of pathological forms of proteins using conjugated polyelectrolytes |
| 07/21/2010 | CN101784558A neurosteroid compounds |
| 07/21/2010 | CN101784556A thiocarbon-protecting groups for rna synthesis |
| 07/21/2010 | CN101784553A 3-spiropyrimidinetrione-quinoline derivatives and their use as antibacterial agents |
| 07/21/2010 | CN101784552A 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof |
| 07/21/2010 | CN101784551A bicycloaniline derivative |
| 07/21/2010 | CN101784550A Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use |
| 07/21/2010 | CN101784549A Novel macrocyclic inhibitors of hepatitis c virus replication |
| 07/21/2010 | CN101784548A Purine derivatives and their use as modulators of Toll-like receptor 7 |
| 07/21/2010 | CN101784547A Pyrazoloquinoline and pyrazolonaphthyridine derivatives as gaba alpha ligands |
| 07/21/2010 | CN101784546A Tricyclic heterocyclic compounds as gaba a modulators |
| 07/21/2010 | CN101784545A Compounds useful as raf kinase inhibitors |
| 07/21/2010 | CN101784544A thiadiazinone derivatives |
| 07/21/2010 | CN101784542A Imidazolone derivatives, preparation method thereof and biological use of same |
| 07/21/2010 | CN101784539A 2-heteroarylamino-pyrimidine derivatives as kinase inhibitors |
| 07/21/2010 | CN101784538A Pyridoneamide derivatives as focal adhesion kinase (FAK) inhibitors and their use for the treatment of cancer |
| 07/21/2010 | CN101784535A Novel dicarboxylic acid derivatives as S1P1 receptor agonists |
| 07/21/2010 | CN101784533A 4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy |
| 07/21/2010 | CN101784532A Novel HIV reverse transcriptase inhibitors |
| 07/21/2010 | CN101784530A 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors |
| 07/21/2010 | CN101784529A Urea and carbamate derivatives as non-nucleoside reverse transcriptase inhibitors |
| 07/21/2010 | CN101784528A Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof |